Immunology - Xconomy

by in

Entry	Author	Date	Location
XBiotech Takes Aim at Inflammation That Weakens Cancer Patients	Bernadette Tansey	05/17/13	Texas
End of the Road for Torrey Path as Founder Starts New Trail with Sequencethree	Bruce V. Bigelow	06/14/11	San Diego
Immune Design, Developer of New Vaccines, Adds Former Elan President as New CEO	Luke Timmerman	04/27/11	Seattle
Adimab Inks Novartis Deal, GSK-Founded Tempero Pursues Hot Immunology Field, Metamark Gets $22M, & More Boston-Area Life Sciences News	Erin Kutz	07/16/10	Boston
Glaxo’s Tempero Pharma Advances on Hot Niche of Immunology	Ryan McBride	07/15/10	Boston
Nathan Myhrvold, Lee Hood Forge Longstanding Partnership at Nexus of IT and Biology	Luke Timmerman	03/24/10	Seattle
Amgen’s Seattle and Boston Teams Seek to Boost Biotech Hit Rate 20 to 30 Percent	Luke Timmerman	10/09/09	National
Biotech Pioneer Steve Gillis on Life as a VC, How Today’s Entrepreneurs Can Make It, and Seattle’s Future in Life Sciences (Part 1)	Luke Timmerman	09/23/09	Seattle
Seattle-based Kineta, New Biotech Startup, Unveils Plan to Trigger Innate Immunity	Luke Timmerman	12/09/08	Seattle
Paul Allen’s WWII Planes Show How Innovation Can Soar Ahead	Luke Timmerman	08/21/08	Seattle
Immune Design Aiming To Make Vaccines That Work Better in a Single Shot	Luke Timmerman	07/07/08	Seattle
Immune Design, Led By Star Scientists, Raises $18 Million To Build Vaccine Company	Luke Timmerman	06/23/08	Seattle
Page 1 of 1

Xconomy National